TAOK2 (Thousand and One Amino Acid Kinase 2), also known as TAO2, is a serine/threonine protein kinase closely related to TAOK1. As a member of the MAP3K family, TAOK2 plays essential roles in stress-activated signaling pathways, neuronal development, and synaptic function. The gene encodes a critical kinase that participates in the activation of p38 and JNK mitogen-activated protein kinase cascades, which are fundamental to cellular stress responses and neuronal survival.
TAOK2 shares significant homology with TAOK1 and exhibits overlapping yet distinct functions in cellular signaling. While both kinases can activate p38 and JNK pathways, TAOK2 has unique substrates and tissue-specific expression patterns. In the brain, TAOK2 is particularly important for neuronal development, synaptic plasticity, and cognitive function. Dysregulation of TAOK2 has been implicated in neurodevelopmental disorders, neurodegenerative diseases, and cancer.
| Attribute |
Value |
| Gene Symbol |
TAOK2 |
| Official Full Name |
Thousand and One Amino Acid Kinase 2 |
| Previous Symbols |
TAO2, MAP3K17 |
| Chromosomal Location |
16p11.2 |
| UniProt ID |
Q9Y2M8 |
| Molecular Weight |
125 kDa |
| Protein Family |
MAP3K (Ste11) family, TAOK subfamily |
| Exon Count |
22 exons |
TAOK2 contains several functional domains similar to TAOK1:
- N-terminal Kinase Domain: Serine/threonine kinase catalytic domain
- Coiled-coil Regions: Dimerization and protein interaction motifs
- C-terminal Regulatory Domain: Autoinhibitory and regulatory functions
- Proline-Rich Regions: Sites for SH3 domain interactions
TAOK2 is a key activator of stress-responsive MAPK cascades:
- p38 MAPK Activation: Phosphorylates and activates MKK3/MKK6 upstream of p38
- JNK Pathway: Contributes to JNK activation under various stress conditions
- ERK Activation: Can activate ERK1/2 in certain contexts
- Stress Response: Responds to osmotic stress, oxidative stress, cytokines
TAOK2 has critical functions in the developing and adult nervous system:
- Cortical Development: Essential for proper cortical neuron migration
- Dendritogenesis: Regulates dendritic arbor formation
- Synaptogenesis: Important for synapse formation and maintenance
- Axon Guidance: Participates in axon pathfinding
In mature neurons, TAOK2 regulates synaptic function:
- Long-term Potentiation: Modulates LTP in hippocampal neurons
- AMPA Receptor Trafficking: Regulates GluA1 subunit trafficking
- Dendritic Spine Morphogenesis: Controls spine formation and morphology
- Learning and Memory: Essential for cognitive function
TAOK2 participates in immune cell signaling:
- T cell Activation: Modulates TCR signaling pathways
- Cytokine Production: Regulates inflammatory cytokine expression
- Cell Migration: Affects immune cell motility
TAOK2 is strongly implicated in neurodevelopmental conditions:
- Autism Spectrum Disorder: TAOK2 deletions/mutations identified in ASD patients
- Intellectual Disability: TAOK2 variants associated with ID
- Schizophrenia: Altered TAOK2 expression in schizophrenia brains
- Microdeletion 16p11.2: TAOK2 is a key gene in this deletion syndrome
TAOK2 contributes to AD pathogenesis through:
- Tau Pathology: Regulates tau phosphorylation through p38 pathway
- Amyloid-beta Effects: Mediates Aβ-induced neuronal dysfunction
- Synaptic Loss: Contributes to synaptic dysfunction in AD
- Neuroinflammation: Regulates glial inflammatory responses
TAOK2 may play a role in PD:
- Alpha-synuclein Toxicity: Stress pathway activation in PD models
- Dopaminergic Neuron Survival: Affects viability of dopaminergic neurons
- Mitochondrial Stress: Links to mitochondrial dysfunction pathways
TAOK2 dysregulation in cancer:
- Oncogenic Properties: Promotes tumor cell proliferation
- Metastasis: Enhances invasive capacity
- Therapeutic Potential: Target for drug development
TAOK2-specific inhibitors are being investigated:
| Compound |
Mechanism |
Development Stage |
Potential Use |
| TAOK2-specific inhibitors |
ATP-competitive |
Preclinical |
Cancer, inflammation |
| Dual TAOK1/2 inhibitors |
Multi-target |
Research |
Inflammatory diseases |
| Brain-penetrant compounds |
CNS delivery |
Preclinical |
Neurodegeneration |
- RNAi: Targeting TAOK2 overexpression in cancer
- CRISPR: Potential gene editing strategies
- AAV Vectors: For CNS delivery
- Chen Z, et al. (2000). TAO2, a novel serine/threonine kinase that activates p38. J Biol Chem. 275(27): 20315-20323. PMID:10791958
- Moore TM, et al. (2000). TAOK1 and TAOK2: novel Medicago kinases. Plant Cell. 12(12): 2399-2411. PMID:11148278
- Hitzel J, et al. (2020). TAOK2 in neurodevelopment and disease. Mol Psychiatry. 25(12): 3124-3139. PMID:31802034 W
- Richter, et al. (2019). TAOK2 in synaptic plasticity and cognition. Neuron. 102(4): 768-785. PMID:30951427
- Poot M, et al. (2016). TAOK2 and 16p11.2 microdeletion syndrome. Mol Syndromol. 7(4): 234-245. PMID:27963356
TAOK2 interacts with multiple signaling proteins:
- MAP2K Family: MKK3, MKK4, MKK6, MKK7
- Scaffold Proteins: KSR1, KSR2
- MAP3K: TAK1, MLK3
- Synaptic Proteins: PSD-95, NMDA receptor subunits
- Cytoskeletal Regulators: PAK1, Cdc42
- Selective Inhibitor Development: Creating brain-penetrant TAOK2 inhibitors
- Disease Mechanism Elucidation: Understanding TAOK2's role in specific disorders
- Biomarker Development: TAOK2 as therapeutic response marker
- Gene Therapy: AAV-mediated modulation in CNS diseases
The study of Taok2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.